Cinven buys Amdipharm for £367m

Cinven intends to merge the Amdipharm Group with its current portfolio company Mercury Pharma, a speciality pharmaceutical firm the GP acquired in August this year, to create a global business. The Amdipharm Group will operate as a stand-alone entity until the merger.

The firm's founders, who owned the business prior to the sale, will retain a significant minority stake in the combined company.

Company
Founded in 2002 and based in Basildon, the Amdipharm Group markets speciality branded or unbranded pharmaceuticals. The firm has made 18 acquisitions to expand its portfolio of products, which now exceeds 50, and has offices in Jersey, Ireland, the Netherlands and Essex.

The company retails in more than 80 countries and generates revenues of more than £110m.

People
Supraj Rajagopalan is a partner at Cinven.

Advisers
Equity – Jefferies (Corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Buyouts
• United Kingdom
• Cinven